<DOC>
	<DOCNO>NCT01046643</DOCNO>
	<brief_summary>The objective study evaluate neurobiological effect hormone therapy ( HT ) healthy early postmenopausal woman . The study propose project seek define association different hormone form ( estradiol progesterone ) versus placebo brain functional measure . The functional measure include performance volunteer comprehensive neuropsychological testing battery , brain functional response episodic memory ( verbal non-verbal ) challenge well emotional processing determine functional magnetic resonance imaging ( fMRI ) .</brief_summary>
	<brief_title>Early Menopause Hormone Treatment Cognition</brief_title>
	<detailed_description>Specific Aims Aim 1 . To examine effect estradiol alone brain functioning early post-menopausal woman verbal non-verbal cognitive task . Hypothesis : It expect estradiol treatment brain activation prominent hippocampus prefrontal cortical area compare placebo . The magnitude activation region positively correlate task performance scanner result neuropsychological test assess verbal non-verbal delay recall . Aim 2 . To determine effect progesterone alone brain function early postmenopausal woman verbal non-verbal cognitive task . Hypothesis : It expect progesterone treatment brain activation hippocampus prefrontal cortical area decrease compare placebo condition ( within subject ) estradiol condition ( subject ) . Interindividual variation magnitude activation region positively correlate task performance scanner result neuropsychological test assess verbal non-verbal delay recall . Aim 3 . To determine individual effect estradiol progesterone brain function early postmenopausal woman emotional processing stimulus . Hypothesis : During negative stimulus estradiol-treated woman compare placebo group , expect increased activity amygdala , posterior cingulate , orbitofrontal cortex , progesterone-treated woman compare placebo , decrease activity expect brain region .</detailed_description>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Postmenopausal woman Ages 4555 , 6 36 month last menstrual period . Left handedness Acute medical illness Neurologic illness Psychiatric illness Heart disease Thromboembolic disease Liver disease Uncorrected thyroid disease Diabetes Neurological disease Porphyria Allergy estradiol Progesterone lactose Lactose intolerance Claustrophobia Contraindications MRI ( include pacemaker , surgical clip metallic surgical device ) Smoking within last 3 year Use hormone within last 3 month Current past history substance abuse History head injury loss consciousness Medications action central nervous system Endometrial lining great 5mm Ovarian pathology ultrasound Abnormal mammogram Migraines Fasting cholesterol &gt; 300 mg/dl , fast triglyceride &gt; 300 mg/dl Creatinine level &gt; 1.5 mg/dl Aspartate transaminase ( AST ) Alanine transaminase ( ALT ) great two time top normal range Follicle stimulate hormone ( FSH ) value &lt; 40 IU/L estradiol &gt; 40 pg/ml . Subjects HAMD score &gt; 8 , HAMA &gt; 6 screening eligible .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Women</keyword>
	<keyword>Healthy</keyword>
	<keyword>Menopausal</keyword>
	<keyword>Hormone treatment</keyword>
</DOC>